Vanguard Group Inc Seres Therapeutics, Inc. Put Options Transaction History
Vanguard Group Inc
- $5.37 Trillion
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding MCRB
# of Institutions
51Shares Held
36.6MCall Options Held
103KPut Options Held
53K-
Flagship Pioneering Inc. Cambridge, MA23.1MShares$328 Million6.86% of portfolio
-
Black Rock Inc. New York, NY1.76MShares$25 Million0.0% of portfolio
-
Ubs Group Ag1.46MShares$20.7 Million0.0% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA834KShares$11.9 Million0.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA717KShares$10.2 Million0.0% of portfolio
About Seres Therapeutics, Inc.
- Ticker MCRB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 124,072,000
- Market Cap $1.76B
- Description
- Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...